Brian Webster

Kestra Medical Technologies Raises $196M to Expand Commercialization of FDA-Approved Wearable Defibrillator

Kestra Medical Technologies raised $196 million to accelerate commercialization of its FDA-approved Wearable Cardioverter Defibrillator, designed to meet female cardiac patients' needs. The funding round was co-led by Andera Partners, Ally Bridge Group, Longitude Capital, and Omega Funds, increasing total funding to $496 million.